A Clinical Trial to Assess the Impact of an Alcohol Alternative Herbal Tincture on Signs of Stress Anxiety and Sleep Quality.
1 other identifier
interventional
80
1 country
1
Brief Summary
This is a virtual randomized placebo-controlled double-blind trial lasting eight weeks. The trial will assess the effects of a test product on improving sleep quality, promoting a sense of calm, and reducing feelings of stress and anxiety, using a sleep tracker and subject-specific questionnaires. The study involves 80 participants who experience sleep issues and feelings associated with stress and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started May 2024
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2024
CompletedFirst Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2024
CompletedApril 24, 2025
April 1, 2025
3 months
July 11, 2024
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvements in Sleep Quality and Mental Well-Being
Changes in sleep quality, mental well-being, stress, and feelings of anxiety will be assessed using self-assessment questionnaires. Participants will complete these questionnaires at specified intervals throughout the study to evaluate the effectiveness of the herbal tincture compared to the placebo.
Baseline, Week 2, Week 4, Week 6, and Week 8
Secondary Outcomes (1)
Changes in Sleep Length and Quality
Baseline, Week 4, and Week 8
Study Arms (2)
Test Product Arm
EXPERIMENTALParticipants in this arm will receive the test product, which is an alcohol alternative herbal tincture. The intervention includes taking 2 ml of the test product directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.
Placebo Arm
PLACEBO COMPARATORParticipants in this arm will receive a placebo. The intervention includes taking 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.
Interventions
The test product contains organic vegetable glycerin, distilled water, organic elderberries, organic bilberries, organic beetroot juice powder, organic California poppy (whole plant), organic tart cherry, organic hawthorn berries, organic blue vervain (aerial parts), organic ceylon cinnamon bark, organic black pepper fruit, and L-theanine.
The placebo is designed to match the test product in appearance and taste but does not contain the active herbal ingredients. Participants will take 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks. The placebo contains organic vegetable glycerin, distilled water, organic beet juice powder, organic tart cherries, organic ceylon cinnamon chips, and natural green food coloring (derived from spirulina and turmeric).
Eligibility Criteria
You may qualify if:
- Aged 21-65 years
- Male or female
- Good general health
- Experience daily feelings of stress and anxiety within the past two weeks
- Experience daily problems with sleeping, reduced energy levels, and fatigue over the past two weeks
- Have used alcohol products to help relax or sleep within the past two weeks
- Experience tension in the body within the past two weeks
- Experience problems with relaxing in the evening within the past two weeks
- Willing to abstain from alcohol for the duration of the study
- Willing to maintain stable use of other herbal supplements, over-the-counter medications, or prescriptions during the study
You may not qualify if:
- Chronic health conditions, including oncological and psychiatric disorders
- Taking SSRIs, sedative, or blood pressure-lowering medications
- Pregnant, breastfeeding, or planning to conceive within the next three months
- Currently enrolled or planning to enroll in another research trial over the next eight weeks
- History of substance abuse
- Known serious allergic reactions requiring an Epi-Pen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Apothekarylead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double-blind (Participant, Investigator)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 17, 2024
Study Start
May 9, 2024
Primary Completion
August 20, 2024
Study Completion
August 20, 2024
Last Updated
April 24, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share